Home/Filings/4/0001213900-23-002248
4//SEC Filing

Lumira Capital Investment Management Inc. 4

Accession 0001213900-23-002248

CIK 0001540159other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 3:42 PM ET

Size

12.5 KB

Accession

0001213900-23-002248

Insider Transaction Report

Form 4
Period: 2023-01-09
van der Velden Peter
Director10% Owner
Transactions
  • Sale

    Common share

    2023-01-09$2.66/sh132,845$353,6471,764,583 total(indirect: By IRA)
  • Sale

    Common share

    2023-01-09$2.66/sh12,284$32,701163,170 total(indirect: By IRA)
  • Sale

    Common share

    2023-01-10$2.63/sh12,895$33,973150,275 total(indirect: By IRA)
  • Sale

    Common share

    2023-01-10$2.63/sh139,450$367,3951,625,133 total(indirect: By IRA)
Transactions
  • Sale

    Common share

    2023-01-09$2.66/sh12,284$32,701163,170 total(indirect: By IRA)
  • Sale

    Common share

    2023-01-09$2.66/sh132,845$353,6471,764,583 total(indirect: By IRA)
  • Sale

    Common share

    2023-01-10$2.63/sh139,450$367,3951,625,133 total(indirect: By IRA)
  • Sale

    Common share

    2023-01-10$2.63/sh12,895$33,973150,275 total(indirect: By IRA)
Footnotes (1)
  • [F1]This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.

Documents

1 file

Issuer

Edesa Biotech, Inc.

CIK 0001540159

Entity typeother
IncorporatedCanada (Federal Level)

Related Parties

1
  • filerCIK 0001702636

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 3:42 PM ET
Size
12.5 KB